Development of low CD4 counts and serious clinical events during virologic suppression.
A. Kaplan-Meier survival curves for time to first sustained low CD4 count outcome, among subjects with CD4 ≥ 500 at the start of the virologic suppression period.
B. New Clinical Events (CDC C and non-AIDS defining) during the first three years of study follow-up, by CD4 count at event. Only first clinical event for an individual is shown